Square Pharma recommends 42.5% dividend

Dhaka, Bangladesh (BBN) – The Board of Directors of Square Pharmaceuticals Limited has recommended 30 percent cash dividend and 12.50 percent stock dividend for the year ended on March 31, 2015, said an office disclosure on Tuesday.
The Board has also approved BDT 1.55 billion for BMRE, capital machinery and lands for future expansion.
The final approval will come from the annual general meeting (AGM) scheduled to be held on September 16 at 10am RAOWA Convention Hall No. 2, Mohakhali DOHS in the capital Dhaka. Record date is August 13.
The Company has also reported consolidated NAV of BDT 31,093.30 million, consolidated EPS of BDT 10.80 and consolidated NOCFPS of BDT 11.68 for the year ended on March 31, 2015.
There will be no price limit on the trading of the shares of the company today following its corporate declaration.

BBN/SSR/AD

No Subscription? You Are Missing Out!

Join the business leaders of Bangladesh who rely on BBN's original reporting and in-depth analysis on business scenario of the country. We send only one daily email. No Spam Guaranteed!

Your Name (optional)

Your Email (Required) *

Subscribe

Please check your email and confirm your subscription